PRKAR1A Gene Myxoma Intracardiac NGS Genetic DNA Test
Introduction to the PRKAR1A Gene Myxoma Intracardiac NGS Genetic DNA Test
The PRKAR1A Gene Myxoma Intracardiac NGS Genetic DNA Test is a state-of-the-art diagnostic tool that leverages Next Generation Sequencing (NGS) technology to analyze the PRKAR1A gene, which is associated with the development of myxomas, benign tumors that can occur in the heart. Understanding the genetic basis of myxoma is essential for early diagnosis and management, especially for individuals with a family history of this condition.
What the Test Measures
This genetic test specifically detects mutations in the PRKAR1A gene, which can indicate a predisposition to developing cardiac myxomas. Early identification of these mutations is crucial for preventive healthcare strategies.
Who Should Consider This Test?
Individuals who should consider the PRKAR1A Gene Myxoma Intracardiac NGS Genetic DNA Test include:
- Those with a family history of myxomas or related cardiac conditions.
- Patients presenting symptoms such as unexplained cardiac issues or tumors.
- Individuals with known genetic disorders that may predispose them to myxoma.
Benefits of Taking the Test
Taking the PRKAR1A Gene Myxoma Intracardiac NGS Genetic DNA Test offers several benefits:
- Early detection of genetic predispositions, allowing for proactive management.
- Informed decision-making regarding treatment and lifestyle adjustments.
- Genetic counseling support for affected family members.
Understanding Your Results
Results from the PRKAR1A Gene Myxoma Intracardiac NGS Genetic DNA Test will be provided in a comprehensive report. It is essential to discuss these results with a healthcare provider, who can guide you on the implications and next steps based on your genetic profile.
Test Pricing
| Price Type | Price (NGN) |
|---|---|
| Discount Price | 400,000 NGN |
| Regular Price | 560,000 NGN |
Book Your Test Today
To book the PRKAR1A Gene Myxoma Intracardiac NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with scheduling your appointment and answering any questions you may have.
Additional Information
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: A clinical history of the patient is required, along with a genetic counseling session to draw a pedigree chart of family members affected with the PRKAR1A Gene Myxoma.
Specialty: Oncologist
Department: Genetics
Method: NGS Technology
Disease Type: Cancer
